Latest news for Findit Inc (OTC:FDIT) Stock

Findit Inc

2024 Full Year Financial Guidance
<ul>
<li>Total revenue guidance increased to be in the range of $530 million to $550 million (previously $500 million to $530 million)</li>
<li>Crysvita revenue expected to be towards the upper end of the range of $375 million to $400 million. This includes all regions where Ultragenyx will recognize revenue: product sales in Latin America and Turkey, royalties in Europe, which have been ongoing, and royalties in North America, which began in April 2023.</li>
<li>Dojolvi revenue in the range of $75 million to $80 million</li>
<li>Net Cash Used in Operations less than $400 million</li>
</ul>

News

Guidance

RARE

Ultragenyx Pharmaceutical Raises FY24 Revenue Guidance From $500M-$530M To $530M-$550M Vs $513.16M Est.

COIN

Coinbase Sees Q3 Subscription And Services Revenue $530M-$600M

PROCEPT BioRobotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRCT#NASDAQ">PRCT</a>) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.52) by 3.85 percent. The company reported quarterly sales of $53.353 million which beat the analyst consensus estimate of $50.164 million by 6.36 percent. This is a 61.17 percent increase over sales of $33.104 million the same period last year.

Earnings

Earnings Beats

PRCT

PROCEPT BioRobotics Q2 2024 GAAP EPS $(0.50) Beats $(0.52) Estimate, Sales $53.353M Beat $50.164M Estimate

Ultragenyx Pharmaceutical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RARE#NASDAQ">RARE</a>) reported quarterly losses of $(1.52) per share which beat the analyst consensus estimate of $(1.72) by 11.63 percent. This is a 32.44 percent increase over losses of $(2.25) per share from the same period last year. The company reported quarterly sales of $147.03 million which beat the analyst consensus estimate of $123.18 million by 19.36 percent. This is a 35.75 percent increase over sales of $108.31 million the same period last year.

Ultragenyx Pharmaceutical Q2 EPS $(1.52) Beats $(1.72) Estimate, Sales $147.03M Beat $123.18M Estimate

2024 Guidance Update:
SPX is updating full-year 2024 guidance, and is now targeting consolidated revenue of approximately $1.97-$2.02 billion ($1.965-$2.025 billion prior), adjusted EBITDA&#x2A; of $410-$430 million ($390-$420 million prior), and adjusted earnings per share&#x2A; in a range of $5.45-$5.60 ($5.15-$5.40 prior).
Segment and company performance is expected to be as follows:
<figure class="table"> 
<table>
<tbody>
<tr>
<td>Revenue</td>
<td>Segment Income Margin %</td>
<td>&nbsp;</td>
</tr>
<tr>
<td>HVAC</td>
<td>$1,365-$1,405 million ($1,360-$1,400 million prior)</td>
<td>23.00%-24.00% (22.25%-23.25% prior)</td>
</tr>
<tr>
<td>Detection &amp; Measurement</td>
<td>$605-$615 million ($605-$625 million prior)</td>
<td>20.75%-21.75% (20.00%-21.00% prior)</td>
</tr>
<tr>
<td>Total SPX</td>
<td>$1.970-$2.020 billion ($1.965-$2.025 billion prior) &nbsp;</td>
<td>22.30%-23.30% (21.60%-22.60% prior)</td>
</tr>
</tbody>
</table>
</figure>

SPXC

SPX Technologies Raises FY24 EPS Guidance From $5.15-$5.40 To $5.45-$5.60 Vs $5.35 Est.; Raising Revenue Guidance From $1.965B-$2.025B To $1.97B-$2.02B Vs $1.99B Est.

Buybacks

Block Board Approved Increase To Share Repurchase, Authorizing Purchase Of Up To Additional $3B Of Class A Common Stock

Alignment Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALHC#NASDAQ">ALHC</a>) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. The company reported quarterly sales of $681.286 million which beat the analyst consensus estimate of $637.649 million by 6.84 percent. This is a 47.34 percent increase over sales of $462.379 million the same period last year.

ALHC

Alignment Healthcare Q2 2024 GAAP EPS $(0.13) Beats $(0.14) Estimate, Sales $681.286M Beat $637.649M Estimate

Motorola Solutions Sees FY 2024 Revenue Growth Of 8%, Non-GAAP EPS $13.22-$13.30 With 171M Fully Diluted Shares And 23.5% Non-GAAP Effective Tax Rate

Dividends

ResMed Increases Quarterly Dividend From $0.48 To $0.53

Motorola Solutions Sees Q3 2024 Revenue Growth Of 7%-8% YoY, Non-GAAP EPS $3.32-$3.37 With 170M Fully Diluted Shares And 24% Non-GAAP Effective Tax Rate

Trading Halt: Halt status updated at 4:25:00 PM ET: Quotation Resumption: News and Resumption Times

Regenxbio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGNX#NASDAQ">RGNX</a>) reported quarterly losses of $(1.05) per share which beat the analyst consensus estimate of $(1.29) by 18.6 percent. This is a 36.75 percent increase over losses of $(1.66) per share from the same period last year. The company reported quarterly sales of $22.295 million which missed the analyst consensus estimate of $22.973 million by 2.95 percent. This is a 11.60 percent increase over sales of $19.977 million the same period last year.

Earnings Misses

RGNX

Regenxbio Q2 2024 GAAP EPS $(1.05) Beats $(1.29) Estimate, Sales $22.295M Miss $22.973M Estimate

Cryptocurrency markets are trading lower, with $2.9 billion in crypto options expiring tomorrow.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$63,362</td>
<td>-2.8%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)&nbsp;&nbsp;</td>
<td>$3,130.8</td>
<td>-3.7%</td>
</tr>
<tr>
<td>Solana&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$161.2</td>
<td>-7.8%</td>
</tr>
<tr>
<td>Dogecoin&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1149</td>
<td>-6.6%</td>
</tr>
<tr>
<td>Shiba Inu&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001524</td>
<td>-5.1%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows a 1.8% increase in large transaction volumes and a 10.9% rise in daily active addresses. &nbsp;However, exchange netflows narrowed by 232.6%.</li>
<li>Coinglass data noted that 115,377 traders were liquidated in the past 24 hours. Total liquidations came in at $342.6 million. Bitcoin liquidations spiked to the highest levels since July 25.</li>
<li>Deribit exchange <a href="https://x.com/DeribitExchange/status/1818985699766354218">noted</a> that around $2.93 billion in crypto options are set to expire on August 2.</li>
<li>Polymarket data <a href="https://x.com/Polymarket/status/1819063111799730642">shows</a> Trump's odds down 18% since he was shot.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40099280/vice-president-kamala-harris-chances-up-to-43-is-her-crypto-pivot-driving-the-surge">Vice President Kamala Harris Chances Up To 43%: Is Her Crypto Pivot Driving The Surge?</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40090066/bitcoin-a-cia-creation-tucker-carlson-believes-so-they-got-there-first-its-honey-trap">Bitcoin A CIA Creation? Tucker Carlson Believes So: &#8216;They Got There First. It&#8217;s Honey Trap&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/07/40087880/cynthia-lummis-unveils-strategic-bitcoin-reserve-legislation-this-is-our-louisiana-purchas">Cynthia Lummis Unveils Strategic Bitcoin Reserve Legislation: &#8216;This Is Our Louisiana Purchase Moment&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40107228/why-golds-luster-could-ignite-a-digital-gold-bitcoin-rally-10x-research">Why Gold&#8217;s Luster Could Ignite A &#8216;Digital Gold&#8217; Bitcoin Rally: 10x Research</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40110137/mike-novogratz-predicts-kamala-harris-may-soon-embrace-crypto-in-light-of-donald-trumps-pr">Mike Novogratz Predicts Kamala Harris May Soon Embrace Crypto In Light Of Donald Trump&#8217;s Pro-Crypto Stance</a></li>
</ul>
<h3 class="wp-block-heading">Top Losers:</h3>
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price</td>
<td>Gains +/–</td>
</tr>
<tr>
<td>Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>$1.88</td>
<td>-14.7%</td>
</tr>
<tr>
<td>Ordi (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">ORDI</a>)</td>
<td>$31.4</td>
<td>-12.6%</td>
</tr>
<tr>
<td>THORChain (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/rune/usd">RUNE</a>)</td>
<td>$3.8</td>
<td>-12.1%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader IncomeSharks <a href="https://x.com/IncomeSharks/status/1819072631158743476">noted</a> that Bitcoin and the supertrend are holding on.
Crypto Scient <a href="https://x.com/Crypto_Scient/status/1819070106049409482">noted</a> that Bitcoin's monthly close is very bullish and thus any early month drop should be purchased quickly to see a green August. He looks to bid BTC between $60,500 &#8211; $59,500 with a stop-loss below $58,700.
Another crypto trader suggests that if the price is holding above $60,000, dips are for buying. He added that the short-term pullback in BTC resembles the last instance when the ribbons turned green.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> is currently trading within a descending broadening wedge, with the price holding above the MA ribbon support. The hash ribbons have also printed a buy signal. The short-term pullback in BTC resembles the last instance when the ribbons turned green. The price… <a href="https://t.co/Q55MszMVx7">pic.twitter.com/Q55MszMVx7</a>
&mdash; Mags (@thescalpingpro) <a href="https://twitter.com/thescalpingpro/status/1819047094340186533?ref_src=twsrc%5Etfw">August 1, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
CryptoCon stated that Bitcoin is down marginally, but people should focus on the "end game…it&#8217;s nothing to worry about." He says, "Hold hope, March 2024 triggered the final weekly bearish KST cross before the cycle top run."
Crypto chart analyst Ali Martinez, in his latest <a href="https://x.com/ali_charts/status/1819069989346771418">post</a>, analyzed the $2.50 billion in leveraged long positions that got liquidated as BTC dipped below $63,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">A bunch of <a href="https://twitter.com/hashtag/Bitcoin?src=hash&amp;ref_src=twsrc%5Etfw">#Bitcoin</a> bulls got rekt in this downswing. According to data from <a href="https://twitter.com/coinglass_com?ref_src=twsrc%5Etfw">@coinglass_com</a>, over $2.50 billion in leveraged long positions got liquidated as <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> dipped below $63,000! Now, bears are getting cocky. But nearly $2.40 billion in leveraged short positions will be… <a href="https://t.co/QHULbk8vWy">pic.twitter.com/QHULbk8vWy</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1819069989346771418?ref_src=twsrc%5Etfw">August 1, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
What&#8217;s Next: The influence of&nbsp;<a href="https://www.benzinga.com/money/is-bitcoin-a-good-investment" target="_blank" rel="noreferrer noopener">Bitcoin as an institutional asset class</a>&nbsp;is expected to be thoroughly explored at Benzinga&#8217;s upcoming&nbsp;<a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a>&nbsp;event on Nov. 19.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/08/40101355/bitcoins-joined-the-big-leagues-but-were-not-bullish-enough-says-bitwise-cio-matt-hougan">Bitcoin&#8217;s Joined The Big Leagues, But: &#8216;We&#8217;re Not Bullish Enough,&#8217; Says Bitwise CIO Matt Hougan</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DOGE

$ETH

$ORDI

$RUNE

$SHIB

$SOL

$WIF

Bitcoin, Ethereum, Dogecoin Move Lower Ahead Of Crypto Options Expiry: 'Bears Are Getting Cocky,' Analyst Says

SPX Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPXC#NYSE">SPXC</a>) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $1.25 by 13.6 percent. This is a 33.96 percent increase over earnings of $1.06 per share from the same period last year. The company reported quarterly sales of $501.30 million which beat the analyst consensus estimate of $492.08 million by 1.87 percent. This is a 18.43 percent increase over sales of $423.30 million the same period last year.

SPX Techs Q2 Adj $1.42 Beats $1.25 Estimate, Sales $501.30M Beat $492.08M Estimate

Founded in 1948, Stavola is an aggregates-led and vertically integrated construction materials company primarily serving the New York-New Jersey Metropolitan Statistical Area (&quot;MSA&quot;) through its network of five hard rock natural aggregates quarries, twelve asphalt plants, and three recycled aggregates sites.
For the last twelve months ended June 30, 2024 (&quot;LTM&quot;), Stavola generated revenues of&nbsp;$283 million&nbsp;and Adjusted EBITDA of&nbsp;$100 million, representing a&nbsp;35%&nbsp;Adjusted EBITDA Margin. The aggregates business contributed&nbsp;56%&nbsp;to Stavola&#39;s LTM Adjusted EBITDA.
The structure of the transaction is expected to create tax benefits attributable to Arcosa with a net present value of approximately&nbsp;$125 million.

Arcosa Agrees To Acquire The Construction Materials Business Of Stavola Holding And Its Affiliated Entities For $1.2BB Cash

Universal Display (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLED#NASDAQ">OLED</a>) reported quarterly earnings of $1.10 per share which missed the analyst consensus estimate of $1.14 by 3.51 percent. The company reported quarterly sales of $158.505 million which missed the analyst consensus estimate of $159.461 million by 0.60 percent. This is a 8.15 percent increase over sales of $146.565 million the same period last year.

OLED

Universal Display Q2 2024 GAAP EPS $1.10 Misses $1.14 Estimate, Sales $158.505M Miss $159.461M Estimate

Motorola Solns (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) reported quarterly earnings of $3.24 per share which beat the analyst consensus estimate of $3.01 by 7.64 percent. The company reported quarterly sales of $2.63 billion which beat the analyst consensus estimate of $2.59 billion by 1.63 percent. This is a 9.36 percent increase over sales of $2.40 billion the same period last year.

Motorola Solns Q2 2024 Adj EPS $3.24 Beats $3.01 Estimate, Sales $2.63B Beat $2.59B Estimate

TD Cowen analyst Andrew Charles reiterates Wingstop (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) with a Buy and maintains $450 price target.

Price Target

Reiteration

Analyst Ratings

WING

TD Cowen Reiterates Buy on Wingstop, Maintains $450 Price Target

Ardelyx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARDX#NASDAQ">ARDX</a>) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 30 percent. This is a 12.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $73.222 million which beat the analyst consensus estimate of $55.019 million by 33.09 percent. This is a 227.86 percent increase over sales of $22.333 million the same period last year.

ARDX

Ardelyx Q2 2024 GAAP EPS $(0.07) Beats $(0.10) Estimate, Sales $73.222M Beat $55.019M Estimate

Third Quarter and Full Year 2024 Outlook:
Procore is providing the following guidance for the third quarter and full year 2024:
<ul>
<li>Third Quarter 2024 Outlook:
<ul>
<li>Revenue is expected to be in the range of $286 million to $288 million, representing year-over-year growth of 15% to 16%.</li>
<li>Non-GAAP operating margin is expected to be in the range of 9% to 10%.</li>
</ul>
</li>
<li>Full Year 2024 Outlook:
<ul>
<li>Revenue is expected to be in the range of $1,141 million to $1,144 million, representing year-over-year growth of 20%.</li>
<li>Non-GAAP operating margin is expected to be in the range of 10% to 11%.</li>
</ul>
</li>
</ul>
A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of expenses that may be incurred in the future and cannot be reasonably determined or predicted at this time, although it is important to note that these factors could be material to Procore's future GAAP financial results.

PCOR

Procore Technologies Sees Q3 Revenue $286M-$288M Vs $291.7M Est.; FY24 Revenue $1.141B-$1.144B Vs $1.14B Est.

Contracts

Press Releases

FINDIT, Inc. (Ticker: FDIT) Files 14C Disclosing Merger Agreement with BioRegenx, Inc.

BioRegenx, Inc. Solidifies Position with Acquisition of DocSun Biomedical Holdings, Inc.

BioRegenx,Inc. Completes Merger into FindIt, Inc. and Launches Updated Version of the GlycoCheck HD CapiScope

CORRECTION FROM SOURCE: BioRegenx, Inc. Completes Merger into FindIt, Inc. and Launches Updated Version of the GlycoCheck HD CapiScope

Events

BioRegenx to Showcase Innovative Health Solutions at 36th Annual Roth Conference

FDIT

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

The Only Monthly Membership With a Positive ROI!

-

-

-

-

-

-

-

Comments

Findit Inc

News

Latest news for Findit Inc (OTC:FDIT) Stock